Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. POS AM Other Post-effective Amendment for Registration Statement
  2. POS AM Other Post-effective Amendment for Registration Statement
  3. EFFECT Other Notice of Effectiveness
  4. DEFA14A Proxy Proxy Materials
  5. DEFA14A Proxy Proxy Materials
  6. DEFA14A Proxy Proxy Materials
  7. DEFA14A Proxy Proxy Materials
  8. DEFA14A Proxy Proxy Materials
  9. ARS Other Annual Report to Security Holders
  10. EFFECT Other Notice of Effectiveness
  11. EFFECT Other Notice of Effectiveness
  12. DEFA14A Proxy Proxy Materials
  13. DEFA14A Proxy Proxy Materials
  14. DEFA14A Proxy Proxy Materials
  15. DEFA14A Proxy Proxy Materials
  16. DEFA14A Proxy Proxy Materials
  17. DEFA14A Proxy Proxy Materials
  18. DEFA14A Proxy Proxy Materials
  19. DEFA14A Proxy Proxy Materials
  20. NT 10-Q Other NT 10-Q

Page 2 of 13 · 258 filings